Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$2.85 - $4.4 $267,367 - $412,777
-93,813 Reduced 87.28%
13,676 $38,000
Q1 2023

May 12, 2023

BUY
$3.14 - $4.2 $99,324 - $132,854
31,632 Added 41.7%
107,489 $423,000
Q4 2022

Feb 10, 2023

BUY
$3.53 - $9.5 $11,214 - $30,181
3,177 Added 4.37%
75,857 $300,000
Q3 2022

Nov 14, 2022

BUY
$5.86 - $9.43 $425,904 - $685,372
72,680 New
72,680 $668,000

Others Institutions Holding MIST

About Milestone Pharmaceuticals Inc.


  • Ticker MIST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,010,900
  • Market Cap $70.8M
  • Description
  • Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...
More about MIST
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.